SMAD2 and osteosarcoma: Eight potential mRNA candidates in osteosarcoma, including Annexin2 [12], Smad2 [13], Methylthioadenosine phosphorylase (MTAP) [14], Cdc42-interacting protein 4 (CIP4) [15], Pigment Epithelium-Derived Factor (PEDF) [16], WW domain-containing oxidoreductase (WWOX) [17], Cell division cycle 5-like (Cdc5L) [18], P27 [19]were selected for quantitative RT-PCR experiments using sera exosomal RNA from 20OS patients with poor chemotherapeutic response, 20OS patients with good chemotherapeutic response, and 20 healthy controls.